Background: Inflammation plays a key role in atherosclerotic plaque destabilization and
adverse cardiac remodeling. Recent evidence has shown a promising role of colchicine in …

Aim. Colchicine as an anti‐inflammatory drug might be effective in the treatment of
atherosclerosis, an inflammatory‐based condition. The aim of this systematic review and …

Background Experimental and clinical evidence supports the role of inflammation in
atherosclerosis and its complications. Colchicine is an orally administered, potent …

Introduction Colchicine, thought to exert its effect via reduction of inflammation, has recently
been studied in patients following acute coronary syndromes (ACS). We performed a meta …

Colchicine has demonstrated promising effects in inhibiting local and systemic inflammation
during acute coronary syndrome (ACS). However, the efficacy of colchicine in ACS is …

Abstract Aims The COLchicine Cardiovascular Outcomes Trial (COLCOT) demonstrated the
benefits of targeting inflammation after myocardial infarction (MI). We aimed to determine …

Purpose This review of colchicine, an effective anti-inflammatory agent, examines whether
the reduction in ischemic events produced by colchicine translates to a reduction in …

Background: Inflammation plays a crucial role in clinical manifestations and complications of
acute coronary syndromes (ACS). Colchicine, a commonly used treatment for gout, has …

Purpose Because inflammation is a key process implicated in the pathogenesis of
atherosclerosis at all stages, including plaque formation, progression, instability, and …

Background Current evidence on the efficacy and safety of colchicine after acute myocardial
infarction (AMI) remains controversial. This study aims to clarify early low-dose long-term …